Literature DB >> 20709787

The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion.

Priya Uppuluri1, Christopher G Pierce, Derek P Thomas, Sarah S Bubeck, Stephen P Saville, Jose L Lopez-Ribot.   

Abstract

The ability of Candida albicans to reversibly switch morphologies is important for biofilm formation and dispersion. In this pathogen, Nrg1p functions as a key negative regulator of the yeast-to-hypha morphogenetic transition. We have previously described a genetically engineered C. albicans tet-NRG1 strain in which NRG1 expression levels can be manipulated by the presence or absence of doxycycline (DOX). Here, we have used this strain to ascertain the role of Nrg1p in regulating the different stages of the C. albicans biofilm developmental cycle. In an in vitro model of biofilm formation, the C. albicans tet-NRG1 strain was able to form mature biofilms only when DOX was present in the medium, but not in the absence of DOX, when high levels of NRG1 expression blocked the yeast-to-hypha transition. However, in a biofilm cell retention assay in which biofilms were developed with mixtures of C. albicans tet-NRG1 and SC5314 strains, tet-NRG1 yeast cells were still incorporated into the mixed biofilms, in which an intricate network of hyphae of the wild-type strain provided for biofilm structural integrity and adhesive interactions. Also, utilizing an in vitro biofilm model under conditions of flow, we demonstrated that C. albicans Nrg1p exerts an exquisite control of the dispersal process, as overexpression of NRG1 leads to increases in dispersion of yeast cells from the biofilms. Our results demonstrate that manipulation of NRG1 gene expression has a profound influence on biofilm formation and biofilm dispersal, thus identifying Nrg1p as a key regulator of the C. albicans biofilm life cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709787      PMCID: PMC2950430          DOI: 10.1128/EC.00111-10

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  36 in total

1.  Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

2.  Unique aspects of gene expression during Candida albicans mating and possible G(1) dependency.

Authors:  Rui Zhao; Karla J Daniels; Shawn R Lockhart; Kathleen M Yeater; Lois L Hoyer; David R Soll
Journal:  Eukaryot Cell       Date:  2005-07

3.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

4.  A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.

Authors:  Prasanna D Khot; Peter A Suci; R Lance Miller; Raoul D Nelson; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

5.  Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans.

Authors:  M Gerami-Nejad; J Berman; C A Gale
Journal:  Yeast       Date:  2001-06-30       Impact factor: 3.239

6.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces.

Authors:  Xiaomin Zhao; Karla J Daniels; Soon-Hwan Oh; Clayton B Green; Kathleen M Yeater; David R Soll; Lois L Hoyer
Journal:  Microbiology (Reading)       Date:  2006-08       Impact factor: 2.777

8.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

9.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

10.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more
  40 in total

Review 1.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

2.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

Review 3.  Coevolution of morphology and virulence in Candida species.

Authors:  Delma S Thompson; Patricia L Carlisle; David Kadosh
Journal:  Eukaryot Cell       Date:  2011-07-15

4.  The role of Mss11 in Candida albicans biofilm formation.

Authors:  Pei-Wen Tsai; Yu-Ting Chen; Cheng-Yao Yang; Hsueh-Fen Chen; Te-Sheng Tan; Tzung-Wei Lin; Wen-Ping Hsieh; Chung-Yu Lan
Journal:  Mol Genet Genomics       Date:  2014-04-22       Impact factor: 3.291

5.  A recently evolved transcriptional network controls biofilm development in Candida albicans.

Authors:  Clarissa J Nobile; Emily P Fox; Jeniel E Nett; Trevor R Sorrells; Quinn M Mitrovich; Aaron D Hernday; Brian B Tuch; David R Andes; Alexander D Johnson
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

6.  Assessment and Optimizations of Candida albicans In Vitro Biofilm Assays.

Authors:  Matthew B Lohse; Megha Gulati; Ashley Valle Arevalo; Adam Fishburn; Alexander D Johnson; Clarissa J Nobile
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 7.  Microbial interactions in building of communities.

Authors:  C J Wright; L H Burns; A A Jack; C R Back; L C Dutton; A H Nobbs; R J Lamont; H F Jenkinson
Journal:  Mol Oral Microbiol       Date:  2012-12-17       Impact factor: 3.563

8.  Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41-dependent mechanisms.

Authors:  Mohua Banerjee; Priya Uppuluri; Xiang R Zhao; Patricia L Carlisle; Geethanjali Vipulanandan; Cristina C Villar; José L López-Ribot; David Kadosh
Journal:  Eukaryot Cell       Date:  2012-12-07

9.  Real-time microscopic observation of Candida biofilm development and effects due to micafungin and fluconazole.

Authors:  Yukihiro Kaneko; Susumu Miyagawa; On Takeda; Masateru Hakariya; Satoru Matsumoto; Hideaki Ohno; Yoshitsugu Miyazaki
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Roles of RPS41 in Biofilm Formation, Virulence, and Hydrogen Peroxide Sensitivity in Candida albicans.

Authors:  Hui Lu; Juan Xiong; Qinghua Shang; Yuanying Jiang; Yingying Cao
Journal:  Curr Microbiol       Date:  2016-03-07       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.